Literature DB >> 6375489

A method for comparing the peak intensity and duration of action of aerosolized bronchodilators using bronchoprovocation with methacholine.

R C Ahrens, A C Bonham, G A Maxwell, M M Weinberger.   

Abstract

The effects of aerosolized metaproterenol (1.30 mg) and isoetharine (1.02 mg) on nonspecific airway responsiveness to inhaled methacholine were quantitated and compared in 6 asthmatic subjects for 4 h after dosing. Both metaproterenol and isoetharine demonstrated bronchodilatation and reduced airway responsiveness during the first hour. Isoetharine had lost its bronchodilator effects and its effects on airway responsiveness by 2.25 h. The effects of metaproterenol on airway responsiveness had decreased by half at 2.25 h, while its bronchodilator effect remained maximal. Metaproterenol had no effect on airway responsiveness by 4 h, despite persisting bronchodilatation. Thus, for metaproterenol, there is disparity between duration of bronchodilation and suppression of airway responsiveness. Because methacholine sensitivity is a measure of nonspecific airway responsiveness, which appears to correlate with the severity of asthma, this methodology may provide more relevant information for assessment of duration of effect and estimation of appropriate dosing intervals for maintenance therapy than do more traditional methods.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6375489     DOI: 10.1164/arrd.1984.129.6.903

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Differential responses of asthmatic airways to enantiomers of albuterol. Implications for clinical treatment of asthma.

Authors:  M Perrin-Fayolle; P S Blum; J Morley; M Grosclaude; M T Chambe
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

Review 2.  Functional antagonism: tolerance produced by inhaled beta 2 agonists.

Authors:  D W Cockcroft; V A Swystun
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

3.  Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.

Authors:  M A Higham; A M Sharara; P Wilson; R J Jenkins; G A Glendenning; P W Ind
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

4.  Effect of preservative on the efficacy of terbutaline nebuliser solution in atopic asthma.

Authors:  C K Lai; C H Chan
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

5.  Measuring the bronchial effect of bronchodilating drugs in healthy subjects after methacholine provocation. Salbutamol as a model drug.

Authors:  O P Seppälä; E Iisalo
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Salmeterol protects against hyperventilation-induced bronchoconstriction over 12 hours.

Authors:  D Nowak; R Jörres; K F Rabe; M Lüthke; J Wiessmann; H Magnussen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

7.  A controlled trial of nebulized salbutamol and adrenaline in acute severe asthma.

Authors:  F Abroug; S Nouira; A Bchir; R Boujdaria; S Elatrous; S Bouchoucha
Journal:  Intensive Care Med       Date:  1995-01       Impact factor: 17.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.